Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Exercise-induced endocannabinoid signaling is modulated by intensity.

Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL.

Eur J Appl Physiol. 2013 Apr;113(4):869-75. doi: 10.1007/s00421-012-2495-5. Epub 2012 Sep 19.

PMID:
22990628
2.

Exercise activates the endocannabinoid system.

Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A.

Neuroreport. 2003 Dec 2;14(17):2209-11.

PMID:
14625449
3.

Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'.

Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A.

J Exp Biol. 2012 Apr 15;215(Pt 8):1331-6. doi: 10.1242/jeb.063677.

4.

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.

Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R.

Psychoneuroendocrinology. 2013 Dec;38(12):2952-61. doi: 10.1016/j.psyneuen.2013.08.004. Epub 2013 Sep 10.

5.

Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.

Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E, Di Marzo V, Meeusen R.

Psychoneuroendocrinology. 2012 Jun;37(6):844-51. doi: 10.1016/j.psyneuen.2011.09.017. Epub 2011 Oct 24.

PMID:
22029953
6.

Effects of exercise stress on the endocannabinoid system in humans under field conditions.

Feuerecker M, Hauer D, Toth R, Demetz F, Hölzl J, Thiel M, Kaufmann I, Schelling G, Choukèr A.

Eur J Appl Physiol. 2012 Jul;112(7):2777-81. doi: 10.1007/s00421-011-2237-0. Epub 2011 Nov 19.

PMID:
22101870
7.

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.

Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E.

J Psychopharmacol. 2008 May;22(3):262-9. doi: 10.1177/0269881107083816.

PMID:
18308802
8.

EEG activity and mood in health orientated runners after different exercise intensities.

Schneider S, Askew CD, Diehl J, Mierau A, Kleinert J, Abel T, Carnahan H, Strüder HK.

Physiol Behav. 2009 Mar 23;96(4-5):709-16. doi: 10.1016/j.physbeh.2009.01.007.

PMID:
19385025
9.

Anandamide dysfunction in prodromal and established psychosis.

Leweke FM.

Curr Pharm Des. 2012;18(32):5188-93. Review.

PMID:
22716147
10.

Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system.

Shinjyo N, Piscitelli F, Verde R, Di Marzo V.

J Neurosci Res. 2013 Jul;91(7):943-53. doi: 10.1002/jnr.23231. Epub 2013 Apr 30.

PMID:
23633391
11.

Involvement of the endocannabinoid system in reward processing in the human brain.

van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF.

Psychopharmacology (Berl). 2012 Feb;219(4):981-90. doi: 10.1007/s00213-011-2428-8. Epub 2011 Aug 6.

12.

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.

Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S.

J Mol Cell Cardiol. 2010 Jun;48(6):1187-93. doi: 10.1016/j.yjmcc.2009.10.025. Epub 2009 Nov 26.

PMID:
19931541
13.

Changes in human muscle oxygen saturation and mean fiber conduction velocity during intense dynamic exercise--effect of muscular training status.

Kilen A, Gizzi L, Jensen BR, Farina D, Nordsborg NB.

Muscle Nerve. 2012 Nov;46(5):746-54. doi: 10.1002/mus.23388. Epub 2012 Sep 19.

PMID:
22996286
14.

Mechanisms of exercise-induced hypoalgesia.

Koltyn KF, Brellenthin AG, Cook DB, Sehgal N, Hillard C.

J Pain. 2014 Dec;15(12):1294-1304. doi: 10.1016/j.jpain.2014.09.006.

15.

Possible Anandamide and Palmitoylethanolamide involvement in human stroke.

Naccarato M, Pizzuti D, Petrosino S, Simonetto M, Ferigo L, Grandi FC, Pizzolato G, Di Marzo V.

Lipids Health Dis. 2010 May 14;9:47. doi: 10.1186/1476-511X-9-47.

16.

Prolonged moderate-intensity aerobic exercise does not alter apoptotic signaling and DNA fragmentation in human skeletal muscle.

Quadrilatero J, Bombardier E, Norris SM, Talanian JL, Palmer MS, Logan HM, Tupling AR, Heigenhauser GJ, Spriet LL.

Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E534-47. doi: 10.1152/ajpendo.00678.2009. Epub 2009 Dec 8.

17.

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.

Jumpertz R, Wiesner T, Blüher M, Engeli S, Bátkai S, Wirtz H, Bosse-Henck A, Stumvoll M.

Exp Clin Endocrinol Diabetes. 2010 Oct;118(9):591-5. doi: 10.1055/s-0030-1253344. Epub 2010 Apr 28.

PMID:
20429051
18.

Low-level laser therapy (LLLT) in human progressive-intensity running: effects on exercise performance, skeletal muscle status, and oxidative stress.

De Marchi T, Leal Junior EC, Bortoli C, Tomazoni SS, Lopes-Martins RA, Salvador M.

Lasers Med Sci. 2012 Jan;27(1):231-6. doi: 10.1007/s10103-011-0955-5. Epub 2011 Jul 8.

PMID:
21739259
19.

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.

González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA.

Brain Res. 2002 Nov 1;954(1):73-81.

PMID:
12393235
20.

Endocannabinoid signaling and synaptic plasticity in the brain.

Zhu PJ.

Crit Rev Neurobiol. 2006;18(1-2):113-24. Review.

PMID:
17725514
Items per page

Supplemental Content

Write to the Help Desk